INDUSTRY OVERVIEW
The AI in Biotechnology is Growing at 18% and is expected to reach 28 Billion by 2032. Below mentioned are some of the dynamics shaping the AI in Biotechnology.AI in Biotechnology Market Size in (USD Billion) CAGR Growth Rate 18%
| Study Period | 2020-2032 |
| Market Size (2024): | 8 Billion |
| Market Size (2032): | 28 Billion |
| CAGR (2024 - 2032): | 18% |
| Fastest Growing Region | Europe |
| Dominating Region | North America |
www.www.htfmarketinsights.com
AI in biotechnology automates complex biological data analysis for applications in genomics, drug discovery, agricultural biotech, and industrial enzyme engineering. By identifying patterns in molecular interactions and genetic sequences, AI accelerates R&D, reduces costs, and opens new frontiers in synthetic biology and personalized treatments.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Biotech R&D Efficiency Demand
- Drug Discovery Cost Challenge
- Genomic Pipeline Acceleration
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Data Complexity
- Lab-to-in-silico Interface Gap
- Regulatory Protein Safety Proofs
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- AI protein folding
- Bio-pathway simulations
- AI in fermentation control
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Bio-manufacturing AI Pipelines
- AI In Vaccine Delivery Design
- Genetic-editing Assist AI
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Protein folding AI
- DNA design
- Lab automation AI
- Imaging assays
AI in Biotechnology Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Drug discovery
- Industrial enzymes
- Synthetic biology
- Diagnostics
- Agriculture biotech
AI in Biotechnology Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Europe is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Europe
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- DeepMind (USA/UK)
- Recursion Pharmaceuticals (USA)
- Atomwise (USA)
- BenevolentAI (UK)
- Insilico Medicine (USA)
- Tempus (USA)
- Ginkgo Bioworks (USA)
- Zymergen (USA)
- Owkin (France)
AI in Biotechnology Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2024 |
|
Based Year Market Size (2023) |
8 Billion |
|
Historical Period |
2020 to 2024 |
|
CAGR (2024 to 2032) |
18% |
|
Forecast Period |
2024 to 2032 |
|
Forecasted Period Market Size (2032) |
28 Billion |
|
Scope of the Report |
Segmentation by Type
Segmentation by Application
|
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
DeepMind (USA/UK),Recursion Pharmaceuticals (USA),Atomwise (USA),BenevolentAI (UK),Insilico Medicine (USA),Tempus (USA),Ginkgo Bioworks (USA),Zymergen (USA),Owkin (France) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
AI in Biotechnology - Table of Contents
Chapter 1: Market Preface
- 1.1 Global AI in Biotechnology Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global AI in Biotechnology Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global AI in Biotechnology Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Biotech R&D efficiency demand
- 3.1.2 Drug discovery cost challenge
- 3.1.3 Genomic pipeline acceleration
-
3.2 Available Opportunities
- 3.2.1 Bio-manufacturing AI pipelines
- 3.2.2 AI in vaccine delivery desig
-
3.3 Influencing Trends
- 3.3.1 AI protein folding
- 3.3.2 Bio-pathway simulations
- 3.3.3 AI in fermentati
-
3.4 Challenges
- 3.4.1 Data complexity
- 3.4.2 Lab-to-in-silico interface gap
- 3.4.3 Regulatory p
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global AI in Biotechnology Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of AI in Biotechnology Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: AI in Biotechnology : Competition Benchmarking & Performance Evaluation
- 5.1 Global AI in Biotechnology Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by AI in Biotechnology Revenue 2024
- 5.3 Global AI in Biotechnology Sales Volume by Manufacturers (2024)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 5C’s Analysis
- 5.6 Ansoff Matrix
Chapter 6: Global AI in Biotechnology Market: Company Profiles
- 6.1 DeepMind (USA/UK)
- 6.1.1 DeepMind (USA/UK) Company Overview
- 6.1.2 DeepMind (USA/UK) Product/Service Portfolio & Specifications
- 6.1.3 DeepMind (USA/UK) Key Financial Metrics
- 6.1.4 DeepMind (USA/UK) SWOT Analysis
- 6.1.5 DeepMind (USA/UK) Development Activities
- 6.2 Recursion Pharmaceuticals (USA)
- 6.3 Atomwise (USA)
- 6.4 BenevolentAI (UK)
- 6.5 Insilico Medicine (USA)
- 6.6 Tempus (USA)
- 6.7 Ginkgo Bioworks (USA)
- 6.8 Zymergen (USA)
- 6.9 Owkin (France)
- 6.10 BioSymetrics (USA)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global AI in Biotechnology by Type & Application (2020-2032)
-
7.1 Global AI in Biotechnology Market Revenue Analysis (USD Million) by Type (2020-2024)
- 7.1.1 Protein Folding AI
- 7.1.2 DNA Design
- 7.1.3 Lab Automation AI
- 7.1.4 Imaging Assays
- 7.1.5 Bioinformatics
-
7.2 Global AI in Biotechnology Market Revenue Analysis (USD Million) by Application (2020-2024)
- 7.2.1 Drug Discovery
- 7.2.2 Industrial Enzymes
- 7.2.3 Synthetic Biology
- 7.2.4 Diagnostics
- 7.2.5 Agriculture Biotech
- 7.3 Global AI in Biotechnology Market Revenue Analysis (USD Million) by Type (2024-2032)
- 7.4 Global AI in Biotechnology Market Revenue Analysis (USD Million) by Application (2024-2032)
Chapter 8 : North America AI in Biotechnology Market Breakdown by Country, Type & Application
- 8.1 North America AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 8.2.1 Protein Folding AI
- 8.2.2 DNA Design
- 8.2.3 Lab Automation AI
- 8.2.4 Imaging Assays
- 8.2.5 Bioinformatics
-
8.3 North America AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 8.3.1 Drug Discovery
- 8.3.2 Industrial Enzymes
- 8.3.3 Synthetic Biology
- 8.3.4 Diagnostics
- 8.3.5 Agriculture Biotech
- 8.4 North America AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 8.5 North America AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 8.6 North America AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM AI in Biotechnology Market Breakdown by Country, Type & Application
- 9.1 LATAM AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 9.2.1 Protein Folding AI
- 9.2.2 DNA Design
- 9.2.3 Lab Automation AI
- 9.2.4 Imaging Assays
- 9.2.5 Bioinformatics
-
9.3 LATAM AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 9.3.1 Drug Discovery
- 9.3.2 Industrial Enzymes
- 9.3.3 Synthetic Biology
- 9.3.4 Diagnostics
- 9.3.5 Agriculture Biotech
- 9.4 LATAM AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 9.5 LATAM AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 9.6 LATAM AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 10 : West Europe AI in Biotechnology Market Breakdown by Country, Type & Application
- 10.1 West Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 10.2.1 Protein Folding AI
- 10.2.2 DNA Design
- 10.2.3 Lab Automation AI
- 10.2.4 Imaging Assays
- 10.2.5 Bioinformatics
-
10.3 West Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 10.3.1 Drug Discovery
- 10.3.2 Industrial Enzymes
- 10.3.3 Synthetic Biology
- 10.3.4 Diagnostics
- 10.3.5 Agriculture Biotech
- 10.4 West Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 10.5 West Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 10.6 West Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 11 : Central & Eastern Europe AI in Biotechnology Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 11.2.1 Protein Folding AI
- 11.2.2 DNA Design
- 11.2.3 Lab Automation AI
- 11.2.4 Imaging Assays
- 11.2.5 Bioinformatics
-
11.3 Central & Eastern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 11.3.1 Drug Discovery
- 11.3.2 Industrial Enzymes
- 11.3.3 Synthetic Biology
- 11.3.4 Diagnostics
- 11.3.5 Agriculture Biotech
- 11.4 Central & Eastern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 11.5 Central & Eastern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 11.6 Central & Eastern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 12 : Northern Europe AI in Biotechnology Market Breakdown by Country, Type & Application
- 12.1 Northern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 12.2.1 Protein Folding AI
- 12.2.2 DNA Design
- 12.2.3 Lab Automation AI
- 12.2.4 Imaging Assays
- 12.2.5 Bioinformatics
-
12.3 Northern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 12.3.1 Drug Discovery
- 12.3.2 Industrial Enzymes
- 12.3.3 Synthetic Biology
- 12.3.4 Diagnostics
- 12.3.5 Agriculture Biotech
- 12.4 Northern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 12.5 Northern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 12.6 Northern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 13 : Southern Europe AI in Biotechnology Market Breakdown by Country, Type & Application
- 13.1 Southern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 13.2.1 Protein Folding AI
- 13.2.2 DNA Design
- 13.2.3 Lab Automation AI
- 13.2.4 Imaging Assays
- 13.2.5 Bioinformatics
-
13.3 Southern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 13.3.1 Drug Discovery
- 13.3.2 Industrial Enzymes
- 13.3.3 Synthetic Biology
- 13.3.4 Diagnostics
- 13.3.5 Agriculture Biotech
- 13.4 Southern Europe AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 13.5 Southern Europe AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 13.6 Southern Europe AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 14 : East Asia AI in Biotechnology Market Breakdown by Country, Type & Application
- 14.1 East Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 14.2.1 Protein Folding AI
- 14.2.2 DNA Design
- 14.2.3 Lab Automation AI
- 14.2.4 Imaging Assays
- 14.2.5 Bioinformatics
-
14.3 East Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 14.3.1 Drug Discovery
- 14.3.2 Industrial Enzymes
- 14.3.3 Synthetic Biology
- 14.3.4 Diagnostics
- 14.3.5 Agriculture Biotech
- 14.4 East Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 14.5 East Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 14.6 East Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 15 : Southeast Asia AI in Biotechnology Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 15.2.1 Protein Folding AI
- 15.2.2 DNA Design
- 15.2.3 Lab Automation AI
- 15.2.4 Imaging Assays
- 15.2.5 Bioinformatics
-
15.3 Southeast Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 15.3.1 Drug Discovery
- 15.3.2 Industrial Enzymes
- 15.3.3 Synthetic Biology
- 15.3.4 Diagnostics
- 15.3.5 Agriculture Biotech
- 15.4 Southeast Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 15.5 Southeast Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 15.6 Southeast Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 16 : South Asia AI in Biotechnology Market Breakdown by Country, Type & Application
- 16.1 South Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 16.2.1 Protein Folding AI
- 16.2.2 DNA Design
- 16.2.3 Lab Automation AI
- 16.2.4 Imaging Assays
- 16.2.5 Bioinformatics
-
16.3 South Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 16.3.1 Drug Discovery
- 16.3.2 Industrial Enzymes
- 16.3.3 Synthetic Biology
- 16.3.4 Diagnostics
- 16.3.5 Agriculture Biotech
- 16.4 South Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 16.5 South Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 16.6 South Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 17 : Central Asia AI in Biotechnology Market Breakdown by Country, Type & Application
- 17.1 Central Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 17.2.1 Protein Folding AI
- 17.2.2 DNA Design
- 17.2.3 Lab Automation AI
- 17.2.4 Imaging Assays
- 17.2.5 Bioinformatics
-
17.3 Central Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 17.3.1 Drug Discovery
- 17.3.2 Industrial Enzymes
- 17.3.3 Synthetic Biology
- 17.3.4 Diagnostics
- 17.3.5 Agriculture Biotech
- 17.4 Central Asia AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 17.5 Central Asia AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 17.6 Central Asia AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 18 : Oceania AI in Biotechnology Market Breakdown by Country, Type & Application
- 18.1 Oceania AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 18.2.1 Protein Folding AI
- 18.2.2 DNA Design
- 18.2.3 Lab Automation AI
- 18.2.4 Imaging Assays
- 18.2.5 Bioinformatics
-
18.3 Oceania AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 18.3.1 Drug Discovery
- 18.3.2 Industrial Enzymes
- 18.3.3 Synthetic Biology
- 18.3.4 Diagnostics
- 18.3.5 Agriculture Biotech
- 18.4 Oceania AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 18.5 Oceania AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 18.6 Oceania AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 19 : MEA AI in Biotechnology Market Breakdown by Country, Type & Application
- 19.1 MEA AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 19.2.1 Protein Folding AI
- 19.2.2 DNA Design
- 19.2.3 Lab Automation AI
- 19.2.4 Imaging Assays
- 19.2.5 Bioinformatics
-
19.3 MEA AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 19.3.1 Drug Discovery
- 19.3.2 Industrial Enzymes
- 19.3.3 Synthetic Biology
- 19.3.4 Diagnostics
- 19.3.5 Agriculture Biotech
- 19.4 MEA AI in Biotechnology Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 19.5 MEA AI in Biotechnology Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 19.6 MEA AI in Biotechnology Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The AI in Biotechnology Market is growing at a steady pace over the last few years and is expected to grow at a CAGR of 18% from 2024 to 2032 to reach a market size of 18% 28 Billion
The AI in Biotechnology Market is predicted to grow at a CAGR of 18%.
AI Protein Folding,Bio-pathway Simulations,AI In Fermentation Control,Biotech Image-assist Analytics are seen to make big Impact on AI in Biotechnology Market Growth.
- Biotech R&D Efficiency Demand
- Drug Discovery Cost Challenge
- Genomic Pipeline Acceleration
- Synthetic Biology Advancement
Some of the major roadblocks that industry players have identified are Data Complexity,Lab-to-in-silico Interface Gap,Regulatory Protein Safety Proofs,Model Interpretability.
Some of the opportunities that Analyst at HTF MI have identified in AI in Biotechnology Market are:
- Bio-manufacturing AI Pipelines
- AI In Vaccine Delivery Design
- Genetic-editing Assist AI
- Agritech Biosim Models
New entrants, including competitors from unrelated industries along with players such as DeepMind (USA/UK),Recursion Pharmaceuticals (USA),Atomwise (USA),BenevolentAI (UK),Insilico Medicine (USA),Tempus (USA),Ginkgo Bioworks (USA),Zymergen (USA),Owkin (France),BioSymetrics (USA) Instituting a robust process in Global AI in Biotechnology Market.
The Global AI in Biotechnology Market Study is Broken down by applications such as Drug discovery,Industrial enzymes,Synthetic biology,Diagnostics,Agriculture biotech.
The Global AI in Biotechnology Market Study is segmented by Protein folding AI,DNA design,Lab automation AI,Imaging assays,Bioinformatics.
The Global AI in Biotechnology Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2020 - Base year: 2024. Forecast period**: 2025 to 2032 [** unless otherwise stated]
AI in biotechnology automates complex biological data analysis for applications in genomics, drug discovery, agricultural biotech, and industrial enzyme engineering. By identifying patterns in molecular interactions and genetic sequences, AI accelerates R&D, reduces costs, and opens new frontiers in synthetic biology and personalized treatments.
